The Northern New England Clinical & Translational Research Network (NNE-CTR) is committed to improving health in Vermont communities, with a focus on rurality. Through collaborations with an expanding network engaging our academic institutions, health care organizations, and local community stakeholders, we leverage innovative strategies and technologies to address health and healthcare challenges. Together, we transform research and health infrastructures to meet the needs of our region.
Specialty
Areas
-
Cardiopulmonary & Vascular Disease
-
Oncology
-
Infectious Disease
-
Behavioral Health
Prioritized Clinical Trial Phases
-
Phase II
-
Phase III
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 13 weeks
Site Highlights
-
Generated an overwhelming community response and strong interest in clinical trial participation.
​​
-
History of partnerships with community stakeholders to shape research questions, assess feasibility, and align priorities with community and health system needs.
​​
- Engagement with the National Institutes of Health and IDeA network initiatives at the national level, such as N3C, RECOVER, & RADx-Up.
​
Learn More about NNE-CTR
​​
-
To learn more and connect with the NNE-CTR in Vermont, contact Kim Luebbers